Chudasama, V;
(2018)
Antibody - Drug conjugates (ADC) - Drug discovery today: Technologies.
[Editorial comment].
Drug Discovery Today - Technologies
, 30
pp. 1-2.
10.1016/j.ddtec.2018.11.003.
Preview |
Text
Chudasama_Editorial.pdf - Accepted Version Download (458kB) | Preview |
Abstract
An antibody–drug conjugate (ADC) comprises an antibody covalently attached to highly potent drugs using a bioconjugation technology. As therapeutics, they combine the exquisite specificity of antibodies, enabling discrimination between healthy and diseased tissue, with the cell-killing ability of cytotoxic drugs.
| Type: | Article |
|---|---|
| Title: | Antibody - Drug conjugates (ADC) - Drug discovery today: Technologies |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ddtec.2018.11.003 |
| Publisher version: | https://doi.org/10.1016/j.ddtec.2018.11.003 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Maths and Physical Sciences > Dept of Chemistry |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10064856 |
Downloads since deposit
227Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
